NasdaqCM:CLDXBiotechs
Celldex Therapeutics And 2 Other Undervalued Small Caps With Insider Action In US
The United States market has shown resilience, remaining flat over the last week while achieving a notable 24% increase over the past year, with earnings projected to grow by 15% annually. In this context, identifying promising small-cap stocks like Celldex Therapeutics and others can be key for investors seeking opportunities that align with current market dynamics and insider activity.